Literature DB >> 20219412

The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis.

Yu-Wei Chiu1, Hsi-Feng Tu, I-Kai Wang, Cheng-Hsien Wu, Kuo-Wei Chang, Tsung-Yun Liu, Shou-Yen Kao.   

Abstract

Osteopontin (OPN) is an extracellular matrix protein in hard tissues. The polymorphism in promoter region of OPN gene correlates to different gene expression and might implicate potential roles in tumor progression and metastasis. Immunohistochemistry (IHC) was utilized to detect the OPN expression in 58 oral squamous cell carcinoma (OSCC) tissues and adjacent normal oral mucosa. The differential OPN expression was further analyzed in relation to clinico-pathological features. Genomic DNA was obtained from isolated leukocytes of blood samples of OSCC patients (n=100), and healthy individuals (n=97) from Taiwan. The OPN gene polymorphism was analyzed by direct sequencing. Our result showed OPN expression was significantly higher in OSCC tissues than in the paired adjacent normal tissues (p<0.01). The expression of OPN was significantly associated with nodal metastasis and the more advanced clinical stage (p<0.05). More prevalent -156 insGG/insGG genotype and -443 T/T genotype was found in OSCC patients (p<0.05). A significant difference in -443T/-156GG/-66T and -443C/-156G/-66T haplotypes between OSCC and controls (p<0.05) was also noted. The OPN expression in tumor tissues significantly correlated with -156 insGG/insGG and -156 G/G+insGG/G genotypes (p<0.05). The conclusion is tissue OPN expression correlates to OSCC progression. -156 insGG/insGG genotype is associated with OSCC susceptibility and higher OPN expression. Copyright 2010 Elsevier Ltd. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20219412     DOI: 10.1016/j.oraloncology.2010.01.018

Source DB:  PubMed          Journal:  Oral Oncol        ISSN: 1368-8375            Impact factor:   5.337


  18 in total

1.  SNPs in the promoter region of the osteopontin gene as a possible host factor for sex difference in hepatocellular carcinoma development in patients with HCV.

Authors:  Kazuhiro Hamaoka; Sumiko Nagoshi; Kayoko Sugawara; Kayoko Naiki; Yoshihito Uchida; Mie Inao; Nobuaki Nakayama; Kenji Fujiwara; Satoshi Mochida
Journal:  Hepatol Int       Date:  2012-10-06       Impact factor: 6.047

Review 2.  Osteopontin is a promoter for hepatocellular carcinoma metastasis: a summary of 10 years of studies.

Authors:  Lunxiu Qin
Journal:  Front Med       Date:  2014-01-25       Impact factor: 4.592

3.  Association of osteopontin polymorphism with cancer risk: a meta-analysis.

Authors:  Gang Yang; Xiaoxing Peng; Pengju Guo; Ge Yang
Journal:  Int J Clin Exp Med       Date:  2015-11-15

4.  Human and experimental evidence supporting a role for osteopontin in alcoholic hepatitis.

Authors:  Oriol Morales-Ibanez; Marlene Domínguez; Sung H Ki; Miguel Marcos; Javier F Chaves; Eric Nguyen-Khac; Hakim Houchi; Silvia Affò; Pau Sancho-Bru; José Altamirano; Javier Michelena; Juan Carlos García-Pagán; Juan G Abraldes; Vicente Arroyo; Juan Caballería; Francisco-Javier Laso; Bin Gao; Ramón Bataller
Journal:  Hepatology       Date:  2013-08-19       Impact factor: 17.425

5.  Serum osteopontin, but not OPN gene polymorphism, is associated with LVH in essential hypertensive patients.

Authors:  Xuwei Hou; Zhaohui Hu; Xiaohua Huang; Yan Chen; Xiuying He; Haiying Xu; Ningfu Wang
Journal:  J Mol Med (Berl)       Date:  2013-12-27       Impact factor: 4.599

6.  Osteopontin's colocalization with the adhesion molecule CEACAM5 in cytoplasm of carcinoma of tongue and its correlation with the invasion of that diease.

Authors:  Fan Zhang; Xu Jin Liu; Xun Qu; Zhen Sheng Hu; Yong Mei Yang; Ling Ma; Pei Liu; Ping Shi; Feng Cai Wei
Journal:  Cancer Cell Int       Date:  2012-06-27       Impact factor: 5.722

7.  OPN gene polymorphisms influence the risk of knee OA and OPN levels in synovial fluid in a Chinese population.

Authors:  Yongqing Jiang; Meng Yao; Qingpeng Liu; Changwei Zhou
Journal:  Arthritis Res Ther       Date:  2013-01-05       Impact factor: 5.156

8.  OPN gene polymorphisms, rs17524488 GG/G, rs11730582 T/C, and rs9138 C/A, and cancer risk in a Chinese population.

Authors:  Yuanyuan Mi; Kewei Ren; Feng Dai; Lijie Zhu; Ninghan Feng
Journal:  Sci Rep       Date:  2015-09-15       Impact factor: 4.379

9.  Associations between the Genetic Polymorphisms of Osteopontin Promoter and Susceptibility to Cancer in Chinese Population: A Meta-Analysis.

Authors:  Yulan Liu; Hongbo Lei; Jixiang Zhang; Jun Wang; Kui Li; Weiguo Dong
Journal:  PLoS One       Date:  2015-08-12       Impact factor: 3.240

10.  Association between Osteopontin Promoter Gene Polymorphisms and Haplotypes with Risk of Diabetic Nephropathy.

Authors:  Balneek Singh Cheema; Sreenivasa Iyengar; Rajni Sharma; Harbir Singh Kohli; Anil Bhansali; Madhu Khullar
Journal:  J Clin Med       Date:  2015-06-10       Impact factor: 4.241

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.